Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tretinoin Gel Microsphere 0.04% vs Retin-A Micro in Acne Vulgaris
NCT07469228Phase 1Completed
- Start
- Aug 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tretinoin in acne vulgaris (3 arms). Primary endpoint: Therapeutic Equivalence and Safety at 12 weeks. Started Aug 2025; status: completed.
02
Drugs
tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07469228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07469228.